Acadia Healthcare Company Inc (ACHC) concluded trading on Wednesday at a closing price of $23.84, with 4.55 million shares of worth about $108.51 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -58.12% during that period and on April 16, 2025 the price saw a loss of about -3.60%. Currently the company’s common shares owned by public are about 91.78M shares, out of which, 89.70M shares are available for trading.
Stock saw a price change of -18.08% in past 5 days and over the past one month there was a price change of -18.19%. Year-to-date (YTD), ACHC shares are showing a performance of -39.87% which decreased to -67.39% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $24.71 but also hit the highest price of $82.40 during that period. The average intraday trading volume for Acadia Healthcare Company Inc shares is 1.94 million. The stock is currently trading -15.07% below its 20-day simple moving average (SMA20), while that difference is down -27.26% for SMA50 and it goes to -52.88% lower than SMA200.
Acadia Healthcare Company Inc (NASDAQ: ACHC) currently have 91.78M outstanding shares and institutions hold larger chunk of about 109.11% of that.
The stock has a current market capitalization of $2.20B and its 3Y-monthly beta is at 1.03. PE ratio of stock for trailing 12 months is 8.59, while it has posted earnings per share of $2.78 in the same period. It has Quick Ratio of 0.99 while making debt-to-equity ratio of 0.68. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ACHC, volatility over the week remained 6.40% while standing at 4.98% over the month.
Stock’s fiscal year EPS is expected to drop by -19.53% while it is estimated to increase by 13.39% in next year. EPS is likely to shrink at an annualized rate of -0.99% for next 5-years, compared to annual growth of 17.49% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Barclays on February 28, 2025 offering an Equal weight rating for the stock and assigned a target price range of between $43 and $35 to it. Coverage by KeyBanc Capital Markets stated Acadia Healthcare Company Inc (ACHC) stock as an Overweight in their note to investors on January 07, 2025, suggesting a price target of $70 for the stock. Stock get a Hold rating from Deutsche Bank on April 25, 2024.
